Momenta Pharmaceuticals, Inc. (MNTA)

[rwwine]

Good afternoon marthambles. Fun exercise indeed and offer my following guesses:

1. MNTA receives sole approval for 40mg Copaxone,

2. MNTA shares approval with Mylan.

My guess: In the event of number 1, MNTA increases 40-60%. If 2, MNTA closes UP 10-25%.

Personally it is my belief that MNTA will be solely approved. Mylan delay in obtaining the 20 mg dose suggest to me they are 12-24 months behind MNTA .